Blend of ayurvedic ingredients reduces symptoms of knee osteoarthritis – Indian trial

By Tingmin Koe contact

- Last updated on GMT

A trial involving Indian population has shown that E-OA-07, a blend of ayurvedic ingredients, is able to reduce the symptoms of knee osteoarthritis. ©Getty Images
A trial involving Indian population has shown that E-OA-07, a blend of ayurvedic ingredients, is able to reduce the symptoms of knee osteoarthritis. ©Getty Images

Related tags: India, Knee osteoarthritis, Trial

An ayurvedic botanical-based ingredient has shown to reduce the symptoms of knee osteoarthritis, including knee pain and stiffness, according to an eight-week trial involving Indian participants.

The ingredient E-OA-07 is a blend of seven ayurvedic ingredients, such as ashwagandha, shyonaka (oroxylum indicum), and shunthi (zingiber officinale). 

The trial looked at the efficacy of E-OA-07 at 1,000mg in alleviating the symptoms of moderate-to-severe cases of knee osteoarthritis.

Using the E-OA-07 manufactured and sold by Enovate Biolife under the tradename Lanconone, the results of the trial were recently published in The Journal of Pain Research. 

Forty-four participants aged 40 to 65 completed the randomised, double-blind, placebo-controlled study.  

To qualify for the study, they needed to have a history of joint paint for at least three years, body mass index within the range of 25 to 29.9, and knee joint pain of at least 60, based on a 100-point pain visual-analogue scale score. 

During the study, the treatment group had to take two capsules of E-OA-07, each 500mg, after breakfast. 

To find out the effects of E-OA-07, the participants’ pain scores were then measured based on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and it was found that the treatment group had a lower pain score. 

For instance, the mean pain score of the treatment group had dropped from 14.95 ± 1.72 to 8.14 ± 3.83. 

As for the placebo group, the mean pain score did not show drastic change, hovering between 14.87 ± 1.87 and 14.30 ± 3.81. 

The researchers noted that the effects of E-OA-07 became significant from the 4th week of the study.  

In addition, by the end of the study period, there was a clinically relevant change of 45.55%, 45.91% and 38.19% for pain, stiffness and physical function respectively.

“Overall, results of the present study support the effectiveness and safety of E-OA-07 in individuals suffering from symptoms of knee osteoarthritis,” ​the researchers said. 

Stiffness score 

Besides the improvement in pain score, the stiffness score was also reduced in the treatment group as compared to the placebo group. 

For instance, the stiffness score dropped from 5.38 ± 1.02 to 2.91 ± 1.51 for the treatment group. 

For the placebo group, the score, however, increased from 5.17 ± 1.61 to 5.44 ± 1.62. 

Source: Journal of Pain Research 

Effect Of E-OA-07 On Improving Joint Health and Mobility In Individuals With Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group 

Study

DOI: http://doi.org/10.2147/JPR.S231237

Authors: Shalini Srivastava, et al 

Related news

Related products

show more

Pycnogenol® Improves Visible Signs of Aging

Pycnogenol® Improves Visible Signs of Aging

Horphag Research (USA) Inc. | 08-Aug-2019 | Infographic

Decades of research on Pycnogenol®, French maritime pine bark extract have shown it effectively improves visible signs of aging by improving skin hydration...

How to protect your distributorship’s profit margins

How to protect your distributorship’s profit margins

Oracle NetSuite | 24-Jun-2019 | Technical / White Paper

The right pricing strategy is a critical component that companies can’t afford to overlook and is one of the most important aspects of maintaining profitability...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast